Brought to you by 
Plexxikon completes $27mm Series B round; gets another $15mm
22 Nov 2022
Executive Summary
Small-molecule drug discovery start-up Plexxikon raised $27mm in a Series B private placement to lead investor Walden International. Also participating in the round were other new investors GIMV and AM Pappas, along with return investors Alta Partners, CW Group, Advanced Technology Ventures, and Kumho Group.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Drug Discovery Technologies
- Bioinformatics
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Plexxikon completes $27mm Series B round; gets another $15mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice